These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28093015)
1. Prevalence and incidence of doctor-diagnosed Dupuytren's disease: a population-based study. Nordenskjöld J; Englund M; Zhou C; Atroshi I J Hand Surg Eur Vol; 2017 Sep; 42(7):673-677. PubMed ID: 28093015 [TBL] [Abstract][Full Text] [Related]
2. Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England. Gerber RA; Perry R; Thompson R; Bainbridge C BMC Musculoskelet Disord; 2011 Apr; 12():73. PubMed ID: 21486483 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies. Baltzer H; Binhammer PA Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426 [TBL] [Abstract][Full Text] [Related]
4. A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand. Mehta S; Belcher HJ J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):368-72. PubMed ID: 24486152 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of Dupuytren's contracture and its correlation with degenerative changes of the hands and feet and with criteria of general health. Bergenudd H; Lindgärde F; Nilsson BE J Hand Surg Br; 1993 Apr; 18(2):254-7. PubMed ID: 8501389 [TBL] [Abstract][Full Text] [Related]
6. Dupuytren's interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial. Dias J; Arundel C; Tharmanathan P; Keding A; Welch C; Corbacho B; Armaou M; Leighton P; Bainbridge C; Craigen M; Flett L; Gascoyne S; Hewitt C; James E; James S; Johnson N; Jones J; Knowlson C; Radia P; Torgerson D; Warwick D; Watson M Trials; 2021 Sep; 22(1):671. PubMed ID: 34593024 [TBL] [Abstract][Full Text] [Related]
7. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System. Sefton AK; Smith BJ; Stewart DA J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551 [TBL] [Abstract][Full Text] [Related]
9. [Comparative Cost Effectiveness of Clostridium Histolyticum Collagenase (Xiapex®) and Partial Fasciectomy for the Treatment of Dupuytren's Contracture in Austria]. Neuwirth M; Binter A; Pipam W; Rab M Handchir Mikrochir Plast Chir; 2016 Aug; 48(4):233-8. PubMed ID: 27547932 [TBL] [Abstract][Full Text] [Related]
10. Comparison between Collagenase Injection and Partial Fasciectomy in the Treatment of Dupuytren's Contracture. Tay TK; Tien H; Lim EY Hand Surg; 2015 Oct; 20(3):386-90. PubMed ID: 26387998 [TBL] [Abstract][Full Text] [Related]
11. A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial. Harrison E; Tan W; Mills N; Karantana A; Sprange K; Duley L; Elliott D; Blazeby J; Hollingworth W; Montgomery AA; Davis T Trials; 2017 Aug; 18(1):392. PubMed ID: 28841903 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological study for personal risk factors and quality of life related to Dupuytren's disease in a mountain village of Japan. Tajika T; Kobayashi T; Kaneko T; Tsunoda D; Tsunoda K; Sutou T; Yamamoto A; Takagishi K J Orthop Sci; 2014 Jan; 19(1):64-70. PubMed ID: 24129389 [TBL] [Abstract][Full Text] [Related]
13. One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial. Scherman P; Jenmalm P; Dahlin LB J Hand Surg Eur Vol; 2016 Jul; 41(6):577-82. PubMed ID: 26631343 [TBL] [Abstract][Full Text] [Related]
14. Dupuytren's disease - what's new: a review. Żyluk A Pol Przegl Chir; 2022 Oct; 95(6):53-61. PubMed ID: 38058165 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological profile of Dupuytren's disease in Taiwan (Ethnic Chinese): a nationwide population-based study. Yeh CC; Huang KF; Ho CH; Chen KT; Liu C; Wang JJ; Chu CC BMC Musculoskelet Disord; 2015 Feb; 16():20. PubMed ID: 25881036 [TBL] [Abstract][Full Text] [Related]
16. A study of the repeatability of the diagnosis of Dupuytren's contracture and its prevalence in the grampian region. Lennox IA; Murali SR; Porter R J Hand Surg Br; 1993 Apr; 18(2):258-61. PubMed ID: 8501390 [TBL] [Abstract][Full Text] [Related]
17. Dupuytren's disease: A reality in Black Africa. Coulibaly NF; Doumbia MM; Dembele B; Dia R; Fall MEK; Sane AD; Dieme CB Hand Surg Rehabil; 2020 Oct; 39(5):448-453. PubMed ID: 32380137 [TBL] [Abstract][Full Text] [Related]
19. Hueston revisited: use of acellular dermal matrix following fasciectomy for the treatment of Dupuytren's disease. Terry MJ; Sue GR; Goldberg C; Narayan D Ann Plast Surg; 2014 Dec; 73 Suppl 2():S178-80. PubMed ID: 24691328 [TBL] [Abstract][Full Text] [Related]
20. Dupuytren's disease in the Hispanic population: a 10-year retrospective review. Weinstein AL; Haddock NT; Sharma S Plast Reconstr Surg; 2011 Dec; 128(6):1251-1256. PubMed ID: 22094744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]